Literature DB >> 6114926

Macrophages as primary target cells and mediators of immune dysfunction in African trypanosomiasis.

C M Grosskinsky, B A Askonas.   

Abstract

African trypanosomiasis is accompanied by profound general immunosuppression. The experiments described here were designed to characterize the contribution of macrophages to the immune pathology of this disease. We used peptone-stimulated, uninfected mice and injected them intraperitoneally with lethally irradiated and 35S-labeled Trypanosoma brucei and parasite-specific antisera. Peritoneal macrophages were thus induced to take up in vivo a defined number of trypanosomes. After the phagocytosis of parasites, macrophages were transferred into uninfected syngeneic mice, where they mimicked some of the important immunological changes normally associated with active trypanosome infection: (i) splenic background plaque-forming cells increased nonspecifically and (ii) the specific immune response to sheep erythrocytes was either enhanced or suppressed, depending on the timing of the antigen challenge: priming simultaneously with the transfer of trypanosome-containing macrophages enhanced immune responsiveness; in contrast, if parasite-containing macrophages were transferred and recipient mice were primed 4 days later, the immune response was suppressed. A contribution of suppressor T cells was ruled out by the treatment of peritoneal exudate cells with anti-Thy 1.2 and complement before transfer into recipient mice. The results indicate that macrophages are key cells in the mediation of parasite-induced immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114926      PMCID: PMC350669          DOI: 10.1128/iai.33.1.149-155.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis.

Authors:  K M Hudson; C Byner; J Freeman; R J Terry
Journal:  Nature       Date:  1976-11-18       Impact factor: 49.962

2.  Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis.

Authors:  B M Greenwood
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

3.  Attachment and ingestion of Trypanosoma gambiense to the rat macrophage by specific antiserum.

Authors:  T Takayanagi; Y Nakatake; G L Enriquez
Journal:  J Parasitol       Date:  1974-04       Impact factor: 1.276

4.  Immunosuppression in Gambian trypanosomiasis.

Authors:  B M Greenwood; H C Whittle; D H Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

5.  Immunosuppression in Trypanosoma brucei infections in rats and mice.

Authors:  G M Urquhart; M Murray; P K Murray; F W Jennings; E Bate
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

6.  Immunosuppression during trypanosomiasis.

Authors:  L G Goodwin; D G Green; M W Guy; A Voller
Journal:  Br J Exp Pathol       Date:  1972-02

7.  Dual pathway of B lymphocyte differentiation in vitro.

Authors:  B A Askonas; G E Roelants; K S Mayor-Withey; J L Welstead
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

8.  The role of macrophages in the induction of antibody in x-irradiated animals.

Authors:  R Gallily; M Feldman
Journal:  Immunology       Date:  1967-02       Impact factor: 7.397

9.  Suppression of cell-mediated immunity in experimental African trypanosomiasis.

Authors:  J M Mansfield; J H Wallace
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

10.  THE PARTICULATE HYDROLASES OF MACROPHAGES. II. BIOCHEMICAL AND MORPHOLOGICAL RESPONSE TO PARTICLE INGESTION.

Authors:  Z A COHN; E WIENER
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

View more
  19 in total

1.  Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense.

Authors:  Meiqing Shi; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes.

Authors:  Rebecca Lopez; Karen P Demick; John M Mansfield; Donna M Paulnock
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Suppressor factor of T-cell activation and decreased interleukin 2 activity in experimental African trypanosomiasis.

Authors:  A Alcina; M Fresno
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense.

Authors:  M Oka; Y Ito
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Incubation of trypanosome-derived mitogenic and immunosuppressive products with peritoneal macrophages allows recovery of biological activities from soluble parasite fractions.

Authors:  D L Sacks; G Bancroft; W H Evans; B A Askonas
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

6.  Antibody responses induced by immunization of inbred mice susceptible and resistant to African trypanosomes.

Authors:  L A Mitchell; T W Pearson
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  The role of antibody and complement in the cellular response to Trypanosoma congolense.

Authors:  B Schmitz; M Gehrung; M Thornton; V Speth
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Effects of extracts of Trypanosoma cruzi on immune responses: induction of a nonspecific suppressor factor.

Authors:  R L Tarleton; R Schafer; R E Kuhn
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Authors:  M Sathish; L K Bhutani; A K Sharma; I Nath
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Production of interferons during experimental African trypanosomiasis.

Authors:  G J Bancroft; C J Sutton; A G Morris; B A Askonas
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.